SARMs Raw Powder Flibanserin 167933-07-5 for Female Sex Enhancer

SARMs Raw Powder Flibanserin 167933-07-5 for Female Sex Enhancer

Information
Product Name: Flibanserin
Flibanserin No.: 167933-07-5
Flibanserin Molecular formula: C20H21F3N4O
Flibanserin Molecular weight: 390.4
Flibanserin Content: 98%
Flibanserin Packing: 1KG/Bag
Flibanserin Appearance: White powder
Flibanserin Grade: Pharmaceutical grade

Flibanserin (code name BIMT-17; proposed trade name Girosa) is a drugbeing studied as a non-hormonal treatment for pre-menopausal women withhypoactive sexual desire disorder (HSDD).

What is Flibanserin?
Flibanserin is a novel, non-hormonal drug that has been studied in clinical trials for the treatment of HSDD in premenopausal and postmenopausal women. The application submitted to the FDA is for premenopausal women. Flibanserin is believed to work on key neurotransmitters, or chemicals, in the brain that affect sexual desire. More specifically, it is thought that flibanserin corrects an imbalance of levels of these neurotransmitters by increasing dopamine and norepinephrine (both responsible for sexual excitement) and decreasing serotonin (responsible for sexual inhibition). In clinical studies, flibanserin was evaluated for its ability to increase the frequency of satisfying sexual events, increase the intensity of sexual desire and decrease the associated distress women feel from its loss.

What will be after use
A new drug designed to boost sexual desire in women is controversial for some and eagerly awaited by others, but its hit a potentially serious snag. The drug didn boost womens desire any more than a placebo in two clinical trials. The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels.) Although there was a slight increase in the number of sexually satisfying events flibanserin users had each month, the FDA staff who reviewed the results said the so-called response rate isn "particularly compelling."

Advantage

SARMs Supplying List

If you need more detail, please feel free to contact me,
Thank you in advance!

Contacts Infomation

Contacts:Phoebe

E-mail:

WhatsApp: +86 18872220703